Express Pharma

FEBRUARY 14, 2024

This is because MSF relies on quality-assured vaccines and medicines made in India to treat the people under their care, with its spending on generic medicines procured from India estimated at 95 per cent for HIV, 90 per cent for hepatitis C antivirals, 36 per cent on TB treatments, and 30 per cent on vaccines.

Generic Medicine 103

Generic Medicine Vaccines 103

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunity 97

Immunity Immunization Vaccines Communication 97

pharmaphorum

NOVEMBER 16, 2020

She first joined the EMA in 2002 and filled a number of senior roles at the regulator including head of inspections, head of international liaison and head of international affairs before switching to the WHO in 2016. Emer Cooke.

Vaccines 64

Vaccines Packaging 64

pharmaphorum

FEBRUARY 26, 2021

Weldon became the Chairman and CEO of J&J in 2002. J&J’s size meant that it had the resources to bring to bear against COVID-19 as the pandemic ravaged the world in 2020 and 2021, and the company soon began work on its own vaccine in partnership with the US government. billion the following February.

Vaccines 126

Vaccines Biosimilars Labelling Communication 126

European Pharmaceutical Review

DECEMBER 14, 2023

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4

Medical Records 116

Medical Records Vaccines Hospitals Drug Development 116

pharmaphorum

OCTOBER 12, 2021

The 59-year-old physician worked at J&J’s Janssen pharma unit in the 1990s, and re-joined the group when it acquired Virco and Tibotec in 2002, two companies of which he was CEO and chairman, respectively, to expand its HIV drug pipeline. billion in 2010.

Vaccines 52

Vaccines 52

pharmaphorum

DECEMBER 2, 2020

Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. The era of mega-mergers.

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128

epicur

MARCH 10, 2025

Back when I started with Stokes, around 2002, when you talked to a human medicine doctor about compounding, they didn’t really know what compounding was. ” to “Can we give them a vaccine while they’re being treated?” A medication that may be good for a human may not be good for a cat or a dog.

Compounding 52

Compounding Compounding Pharmacies Customer Service Hospitals 52

pharmaphorum

DECEMBER 15, 2022

Stefan Woxström is the new senior vice president for Europe and Canada at AstraZeneca, moving over from the company’s Japanese division to take over from Iskra Reic , who will now serve as EVP of vaccines and immune therapies. Diaz has been with Almirall since 2002, most recently serving as senior director of corporate strategy.

Immunity 52

Immunity Immunization Vaccines 52

Express Pharma

JANUARY 12, 2024

Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

PharmaShots

APRIL 25, 2023

R&D Expenditure: $883M Founded Year: 2002 Total Employees: ~2000 Headquarters: Massachusetts, United States Market Cap: $25.4B The company strives to discover and develop therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines. R&D Expenditure: $6.6B

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunity 40

Safe Biologics

APRIL 25, 2023

Having served in the Department of Health and Human Services’ Office of the Secretary from 2002-2008, including two years as Associate Deputy HHS Secretary, I participated in the development and implementation of Medicare Part D, the program’s prescription drug benefit. In the meantime, I encourage you to read our comments here. [1]

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

Safe Biologics

APRIL 25, 2023

Having served in the Department of Health and Human Services’ Office of the Secretary from 2002-2008, including two years as Associate Deputy HHS Secretary, I participated in the development and implementation of Medicare Part D, the program’s prescription drug benefit. In the meantime, I encourage you to read our comments here. [1]

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130